Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue - PubMed (original) (raw)
Clinical Trial
Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue
A H Talal et al. J Acquir Immune Defic Syndr. 2001.
Abstract
Objectives: We evaluated virologic and immunologic responses to antiretroviral therapy in gut-associated lymphoid tissue (GALT) compared with those found in peripheral blood.
Methods: Eight HIV-1-infected individuals were treated with three reverse transcriptase inhibitors and one protease inhibitor. Endoscopic biopsies were performed at baseline, and at months 1, 2, and 6. We measured the level of cell-associated multiply spliced and unspliced HIV-1 mRNA in GALT and in peripheral blood mononuclear cells. Immunologic responses were assessed by flow cytometry.
Results: Levels of multiply spliced HIV-1 mRNA declined in parallel fashion both in peripheral blood and GALT. After 6 months of therapy, unspliced HIV-1 mRNA in the GALT was below assay detection although it persisted in peripheral blood mononuclear cells in 4 study subjects. Although the percentage of CD4+ lymphocytes increased significantly in peripheral blood, only modest increases occurred in GALT. The percentage of activated CD8+ T cells decreased significantly in peripheral blood whereas only modest reductions occurred in GALT.
Conclusions: Antiretroviral therapy effectively suppressed HIV-1 replication in GALT. The percentage of CD4+ T cells in peripheral blood uniformly increased in all study subjects, whereas it was more variable in the GALT.
Similar articles
- Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.
Evering TH, Mehandru S, Racz P, Tenner-Racz K, Poles MA, Figueroa A, Mohri H, Markowitz M. Evering TH, et al. PLoS Pathog. 2012 Feb;8(2):e1002506. doi: 10.1371/journal.ppat.1002506. Epub 2012 Feb 2. PLoS Pathog. 2012. PMID: 22319447 Free PMC article. - Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
García F, Plana M, Vidal C, Cruceta A, O'Brien WA, Pantaleo G, Pumarola T, Gallart T, Miró JM, Gatell JM. García F, et al. AIDS. 1999 Jul 30;13(11):F79-86. doi: 10.1097/00002030-199907300-00002. AIDS. 1999. PMID: 10449278 - Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission.
Lafeuillade A, Poggi C, Chadapaud S, Hittinger G, Chouraqui M, Pisapia M, Delbeke E. Lafeuillade A, et al. J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):44-55. doi: 10.1097/00126334-200101010-00006. J Acquir Immune Defic Syndr. 2001. PMID: 11176268 Clinical Trial. - Pathogenesis of HIV in the gastrointestinal tract.
Dandekar S. Dandekar S. Curr HIV/AIDS Rep. 2007 Feb;4(1):10-5. doi: 10.1007/s11904-007-0002-0. Curr HIV/AIDS Rep. 2007. PMID: 17338855 Review. - [Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection].
Vergnon-Miszczycha D, Lucht F, Roblin X, Pozzetto B, Paul S, Bourlet T. Vergnon-Miszczycha D, et al. Med Sci (Paris). 2015 Dec;31(12):1092-101. doi: 10.1051/medsci/20153112012. Epub 2015 Dec 16. Med Sci (Paris). 2015. PMID: 26672662 Review. French.
Cited by
- First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody.
Beckford-Vera DR, Flavell RR, Seo Y, Martinez-Ortiz E, Aslam M, Thanh C, Fehrman E, Pardons M, Kumar S, Deitchman AN, Ravanfar V, Schulte B, Wu IK, Pan T, Reeves JD, Nixon CC, Iyer NS, Torres L, Munter SE, Hyunh T, Petropoulos CJ, Hoh R, Franc BL, Gama L, Koup RA, Mascola JR, Chomont N, Deeks SG, VanBrocklin HF, Henrich TJ. Beckford-Vera DR, et al. Nat Commun. 2022 Mar 9;13(1):1219. doi: 10.1038/s41467-022-28727-5. Nat Commun. 2022. PMID: 35264559 Free PMC article. - The importance of semen leukocytes in HIV-1 transmission and the development of prevention strategies.
Cavarelli M, Le Grand R. Cavarelli M, et al. Hum Vaccin Immunother. 2020 Sep 1;16(9):2018-2032. doi: 10.1080/21645515.2020.1765622. Epub 2020 Jul 2. Hum Vaccin Immunother. 2020. PMID: 32614649 Free PMC article. Review. - Seeing Is Believing: Nuclear Imaging of HIV Persistence.
Henrich TJ, Hsue PY, VanBrocklin H. Henrich TJ, et al. Front Immunol. 2019 Sep 12;10:2077. doi: 10.3389/fimmu.2019.02077. eCollection 2019. Front Immunol. 2019. PMID: 31572355 Free PMC article. Review. - Early treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection.
Santangelo PJ, Cicala C, Byrareddy SN, Ortiz KT, Little D, Lindsay KE, Gumber S, Hong JJ, Jelicic K, Rogers KA, Zurla C, Villinger F, Ansari AA, Fauci AS, Arthos J. Santangelo PJ, et al. Mucosal Immunol. 2018 May;11(3):932-946. doi: 10.1038/mi.2017.112. Epub 2017 Dec 20. Mucosal Immunol. 2018. PMID: 29346349 Free PMC article. - Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure.
Khan S, Telwatte S, Trapecar M, Yukl S, Sanjabi S. Khan S, et al. AIDS Res Hum Retroviruses. 2017 Nov;33(S1):S40-S58. doi: 10.1089/AID.2017.0153. AIDS Res Hum Retroviruses. 2017. PMID: 28882067 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials